Skip to main content

Table 1 Clinical and laboratory data of the estimation and validation groups

From: A newly noninvasive model for prediction of non-alcoholic fatty liver disease: utility of serum prolactin levels

 

Men

Women

Estimation group

Validation group

P

Estimation group

Validation group

P

N

226

226

 

210

211

 

Age (years)

54 (44, 62)

53 (41.5, 61.5)

0.25

56 (46, 64.3)

55 (45, 64)

0.33

BMI (kg/m2)

25.1 (22.9, 27.2)

25.6 (23.4, 27.5)

0.99

134 (120, 150)

134 (121, 146)

0.77

SBP (mmHg)

131 (119, 144)

137 (127, 149.5)

0.01

80 (70, 91.3)

80.5 (71, 89)

0.68

DBP (mmHg)

80 (72, 88)

82 (76, 91)

0.18

24.2 (21.9, 27.6)

24.8 (22.3, 27.5)

0.32

Waist (cm)

94 (88, 98.3)

95 (88, 99)

0.99

89 (80, 98)

88.5 (82.3, 96)

0.85

HbA1c (%)

8.1 (6.5, 9.9)

7.1 (5.9, 9.4)

0.15

7.6 (5.6, 9.4)

6.8 (5.4, 8.7)

0.06

FBG (mmol/L)

7.4 (5.6, 9.2)

6.8 (5.3, 8.8)

0.41

6.1 (4.8, 8.4)

5.6 (4.7, 7.8)

0.10

ALT (U/L)

25.3 (16.9, 41.7)

23.1 (16.6, 34.7)

0.47

20.2 (14.5, 32.4)

19 (13.9, 27.8)

0.21

AST (U/L)

19.7 (16.1, 25.2)

18.3 (15.3, 23.1)

0.33

19.3 (16, 24.6)

18.4 (15, 23.7)

0.15

TG (mmol/L)

1.5 (1.1, 2.4)

1.5 (1.1, 2.2)

0.86

1.4 (1, 2)

1.4 (1, 2)

0.66

TC (mmol/L)

4.4 (3.6, 5.1)

4.5 (3.7, 5)

0.68

4.5 (3.8, 5.3)

4.5 (3.8, 5.2)

0.99

HDL (mmol/l)

1 (0.8, 1.2)

1 (0.8, 1.2)

0.99

1.1 (1, 1.4)

1.1 (1, 1.4)

0.64

LDL (mmol/l)

2.4 (1.8, 3)

2.5 (1.9, 3)

0.45

2.5 (1.9, 3.2)

2.4 (2, 3.1)

0.84

PRL (ug/L)

8.8 (6.5, 12.1)

7.9 (6.3, 10.5)

0.28

9.7 (6.7, 14.2)

9.9 (6.6, 14)

0.98

  1. BMI Body mass index, SBP Systolic blood pressure, DBP Diastolic blood pressure, FBG Fasting blood glucose, HbA1c Haemoglobin 1c, ALT Alanine aminotransferase, AST Aspartate transaminase (AST), HDL High-density lipoprotein, LDL Low-density lipoprotein, PRL Prolactin, TC Total cholesterol, TG triglyceride. Data are shown as median with interquartile range (IQR). p values are based on Mann-Whitney U test